Does Dr. GAUTAM AGGARWAL have financial conflicts of interest?

Dr. GAUTAM AGGARWAL (MD) has received a total of $2,278 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $2,278 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. GAUTAM AGGARWAL?

According to CMS Open Payments data, Dr. GAUTAM AGGARWAL received funding from OLYMPUS CORPORATION OF THE AMERICAS ($1,575), GENZYME CORPORATION ($399), and SANOFI-AVENTIS U.S ($281).

Does Dr. GAUTAM AGGARWAL receive research grants or speaking fees?

Dr. GAUTAM AGGARWAL has received $2,278 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. GAUTAM AGGARWAL

MDReal-Time Hydrated

Specialty: Family Medicine

Practice Location: PHOENIX, AZ 85016

NPI Number: 1700185667

LIFETIME INDUSTRY VALUE

$2,278

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AGGARWAL is a verified Family Medicine practitioner based in PHOENIX, AZ.

Between 2021 and 2024, Dr. AGGARWAL had an overall industry promotional and research financial footprint of $2,278 as recorded in the federal CMS Open Payments database.

$2,278 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AGGARWAL's primary funding source is OLYMPUS CORPORATION OF THE AMERICAS, which accounts for $1,575 (representing 69.1% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

OLYMPUS CORPORATION OF THE AMERICAS

Rank 1

$1,575

69.1%

GENZYME CORPORATION

Rank 2

$399

17.5%

SANOFI-AVENTIS U.S

Rank 3

$281

12.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.